查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1520480

2024-2032 年连续血糖监测系统市场报告（按组成部分、人口统计资料（儿童人口、成人人口）、最终使用者和地区）

Continuous Glucose Monitoring Systems Market Report by Component, Demographics (Child Population, Adult Population ), End User, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 138 Pages | 商品交期: 2-3个工作天内

价格

IMARC Group年，全球连续血糖监测系统市场规模达到67亿美元。

连续血糖监测系统 (CGMS) 是一种技术先进的设备，可自动追踪血糖水平。它们由整合发射器的感测器组成，透过经皮或皮下途径连续测量组织液中的葡萄糖浓度。然后发射器将讯息传送到可以夹在衣服上的无线监视器。连续血糖监测系统有助于提供完整的糖尿病概况，提醒血糖水平的高低，检测模式，并增加患者对身体活动、药物选择、食物份量和压力的了解。与传统的血糖监测设备相比，CGMS 是无刺的，因为它们可以放置在皮肤上，有助于以快速、无痛的方式提供即时资讯。

连续血糖监测系统市场趋势：

全球老年人口不断增加，更容易罹患糖尿病，为市场创造了积极的前景。 CGMS 通常用于测量体内的葡萄糖和胰岛素水平，如果血糖和胰岛素水平下降或上升到危险水平，则会进一步发出警报。与此一致的是，即时识别低血糖和高血糖情况的产品的广泛使用有利于市场成长。此外，CGMS 的重大改进和新技术进步有助于检测糖尿病患者的糖化血红蛋白 (Hb1ac)，这为市场成长提供了相当大的推动力。此外，人工胰臟设备系统与 CGMS 技术的整合可泵送胰岛素并给予最佳剂量以管理患者的血糖水平，这对市场成长产生了积极影响。除此之外，非侵入性 CGMS 设备作为一种方便的替代品的引入、广泛的研发 (R&D) 活动以及对微创或微创诊断工具不断增长的需求预计将推动市场进一步增长。

本报告回答的关键问题

  • 2023年全球连续血糖监测系统市场规模有多大？
  • 2024-2032年全球连续血糖监测系统市场的预期成长率为何？
  • COVID-19 对全球连续血糖监测系统市场有何影响？
  • 推动全球连续血糖监测系统市场的关键因素是什么？
  • 基于组件的全球连续血糖监测系统市场的细分情况如何？
  • 根据人口统计数据，全球连续血糖监测系统市场的细分如何？
  • 基于最终用户的全球连续血糖监测系统市场的细分是什么？
  • 全球连续血糖监测系统市场的关键区域有哪些？
  • 全球连续血糖监测系统市场的主要参与者/公司有哪些？

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 资料来源
    • 主要资源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球连续血糖监测系统市场

  • 市场概况
  • 市场业绩
  • COVID-19 的影响
  • 市场预测

第 6 章：市场区隔：按组成部分

  • 感应器
    • 市场走向
    • 市场预测
  • 发射器和接收器
    • 市场走向
    • 市场预测
  • 集成胰岛素泵
    • 市场走向
    • 市场预测

第 7 章：市场区隔：依人口统计

  • 儿童人口（<=14 岁）
    • 市场走向
    • 市场预测
  • 成人人口（>14 岁）
    • 市场走向
    • 市场预测

第 8 章：市场区隔：依最终用户

  • 诊所和诊断中心
    • 市场走向
    • 市场预测
  • 重症加护病房
    • 市场走向
    • 市场预测
  • 家庭医疗保健
    • 市场走向
    • 市场预测

第 9 章：市场区隔：按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场走向
    • 市场细分：按国家/地区
    • 市场预测

第 10 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 11 章：价值链分析

第 12 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 13 章：价格分析

第14章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • A. Menarini Diagnostics Srl
    • Abbott Laboratories
    • DexCom Inc.
    • F. Hoffmann-La Roche AG
    • Glysens Incorporated
    • LifeScan Inc. (Johnson & Johnson)
    • Medtronic PLC
    • Medtrum Technologies Inc.
    • Nemaura Medical Inc.
    • Novo Nordisk A/S
    • Senseonics Holdings Inc.
    • Waveform Technologies Inc.
Product Code: SR112024A5377

The global continuous glucose monitoring systems market size reached US$ 6.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 10.2 Billion by 2032, exhibiting a growth rate (CAGR) of 5% during 2024-2032.

Continuous glucose monitoring systems (CGMS) are technologically advanced devices that automatically track blood glucose levels. They consist of a transmitter-integrated sensor that functions through a transcutaneous or subcutaneous route to continuously measure the glucose concentration in interstitial fluid. The transmitter then sends the information to a wireless monitor that can be clipped to clothes. Continuous glucose monitoring systems assist in providing a complete profile of diabetes, alerting highs and lows of blood sugar levels, detecting patterns, and increasing patient insights regarding physical activity, medication choices, food portions and stress. As compared to conventional glucose monitoring devices, CGMS are prick-free as they can be placed over the skin, thus aiding in providing real-time information in a quick and painless fashion.

Continuous Glucose Monitoring Systems Market Trends:

The rising geriatric population across the globe that are more susceptible to developing diabetes is creating a positive outlook for the market. CGMS is commonly used for measuring glucose and insulin level in the body, which further sounds an alarm if it drops or rises to a dangerous level. In line with this, the widespread product utilization to identify hypoglycemia and hyperglycemic situations in real-time is favoring the market growth. Moreover, significant improvements and new technological advancements in CGMS that aid in detecting glycated hemoglobin (Hb1ac) in patients with diabetes are providing a considerable boost to the market growth. Additionally, the integration of artificial pancreas device systems with CGMS technology to pump insulin and administer optimum dosage to manage the blood sugar levels of patients is positively impacting the market growth. Apart from this, the introduction of non-invasive CGMS devices as a convenient alternative, extensive research and development (R&D) activities and the increasing demand for less or minimally invasive diagnostic tools are anticipated to drive the market further toward growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global continuous glucose monitoring systems market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on component, demographics and end user.

Breakup by Component:

Sensors

Transmitters and Receivers

Integrated Insulin Pumps

Breakup by Demographics:

Child Population (<=14 years)

Adult Population (>14 years)

Breakup by End User:

Clinics and Diagnostics Centers

ICUs

Home Healthcare

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being A. Menarini Diagnostics S.r.l., Abbott Laboratories, DexCom Inc., F. Hoffmann-La Roche AG, Glysens Incorporated, LifeScan Inc. (Johnson & Johnson), Medtronic PLC, Medtrum Technologies Inc., Nemaura Medical Inc., Novo Nordisk A/S, Senseonics Holdings Inc. and Waveform Technologies Inc.

Key Questions Answered in This Report

  • 1. What was the size of the global continuous glucose monitoring systems market in 2023?
  • 2. What is the expected growth rate of the global continuous glucose monitoring systems market during 2024-2032?
  • 3. What has been the impact of COVID-19 on the global continuous glucose monitoring systems market?
  • 4. What are the key factors driving the global continuous glucose monitoring systems market?
  • 5. What is the breakup of the global continuous glucose monitoring systems market based on the component?
  • 6. What is the breakup of the global continuous glucose monitoring systems market based on the demographics?
  • 7. What is the breakup of the global continuous glucose monitoring systems market based on end user?
  • 8. What are the key regions in the global continuous glucose monitoring systems market?
  • 9. Who are the key players/companies in the global continuous glucose monitoring systems market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Continuous Glucose Monitoring Systems Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Component

  • 6.1 Sensors
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Transmitters and Receivers
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Integrated Insulin Pumps
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Demographics

  • 7.1 Child Population (<=14 years)
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Adult Population (>14 years)
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Clinics and Diagnostics Centers
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 ICUs
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Home Healthcare
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 A. Menarini Diagnostics S.r.l.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
    • 14.3.2 Abbott Laboratories
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 DexCom Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 F. Hoffmann-La Roche AG
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
    • 14.3.5 Glysens Incorporated
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 LifeScan Inc. (Johnson & Johnson)
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 SWOT Analysis
    • 14.3.7 Medtronic PLC
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Medtrum Technologies Inc.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
    • 14.3.9 Nemaura Medical Inc.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
    • 14.3.10 Novo Nordisk A/S
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
    • 14.3.11 Senseonics Holdings Inc.
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
    • 14.3.12 Waveform Technologies Inc.
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio

List of Figures

  • Figure 1: Global: Continuous Glucose Monitoring Systems Market: Major Drivers and Challenges
  • Figure 2: Global: Continuous Glucose Monitoring Systems Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Continuous Glucose Monitoring Systems Market: Breakup by Component (in %), 2023
  • Figure 5: Global: Continuous Glucose Monitoring Systems Market: Breakup by Demographics (in %), 2023
  • Figure 6: Global: Continuous Glucose Monitoring Systems Market: Breakup by End User (in %), 2023
  • Figure 7: Global: Continuous Glucose Monitoring Systems Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Continuous Glucose Monitoring Systems (Sensors) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Continuous Glucose Monitoring Systems (Sensors) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Continuous Glucose Monitoring Systems (Transmitters and Receivers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Continuous Glucose Monitoring Systems (Transmitters and Receivers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Continuous Glucose Monitoring Systems (Integrated Insulin Pumps) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Continuous Glucose Monitoring Systems (Integrated Insulin Pumps) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Continuous Glucose Monitoring Systems (Child Population (<=14 years)) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Continuous Glucose Monitoring Systems (Child Population (<=14 years)) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Continuous Glucose Monitoring Systems (Adult Population (>14 years)) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Continuous Glucose Monitoring Systems (Adult Population (>14 years)) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Continuous Glucose Monitoring Systems (Clinics and Diagnostics Centers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Continuous Glucose Monitoring Systems (Clinics and Diagnostics Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Continuous Glucose Monitoring Systems (ICUs) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Continuous Glucose Monitoring Systems (ICUs) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Continuous Glucose Monitoring Systems (Home Healthcare) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Continuous Glucose Monitoring Systems (Home Healthcare) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: North America: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: North America: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: United States: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: United States: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Canada: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Canada: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Asia-Pacific: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Asia-Pacific: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: China: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: China: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: Japan: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: Japan: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: India: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: India: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: South Korea: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: South Korea: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: Australia: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: Australia: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: Indonesia: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: Indonesia: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: Others: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: Others: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: Europe: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: Europe: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: Germany: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: Germany: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: France: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: France: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: United Kingdom: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: United Kingdom: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: Italy: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: Italy: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: Spain: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: Spain: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: Russia: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: Russia: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Others: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Others: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Latin America: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Latin America: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Brazil: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Brazil: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Mexico: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Mexico: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Others: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Others: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Middle East and Africa: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Middle East and Africa: Continuous Glucose Monitoring Systems Market: Breakup by Country (in %), 2023
  • Figure 72: Middle East and Africa: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 73: Global: Continuous Glucose Monitoring Systems Industry: SWOT Analysis
  • Figure 74: Global: Continuous Glucose Monitoring Systems Industry: Value Chain Analysis
  • Figure 75: Global: Continuous Glucose Monitoring Systems Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Continuous Glucose Monitoring Systems Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Continuous Glucose Monitoring Systems Market Forecast: Breakup by Component (in Million US$), 2024-2032
  • Table 3: Global: Continuous Glucose Monitoring Systems Market Forecast: Breakup by Demographics (in Million US$), 2024-2032
  • Table 4: Global: Continuous Glucose Monitoring Systems Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 5: Global: Continuous Glucose Monitoring Systems Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Continuous Glucose Monitoring Systems Market: Competitive Structure
  • Table 7: Global: Continuous Glucose Monitoring Systems Market: Key Players